66
Z. Rapi et al. / Carbohydrate Research 365 (2013) 61–68
3.2.8. General method for the preparation of compounds 10 and
11
cane (13).
Yield: 0.63 g (30%). ½a D22
ꢀ
+128.7 (c 1, CHCl3); 1H NMR
(CDCl3, 500 MHz), d (ppm): 4.60 (d, J = 3 Hz, 1H), 3.90 (td, J = 12 Hz,
4 Hz, 2H), 3.66–3.50 (m, 12H), 3.43–3.41 (m, 1H), 3.41 (s, 3H), 3.33
(s, 3H), 3.18 (td, J = 10.5 Hz, 4 Hz, 1H), 2.87–2.80 (m, 2H), 2.79–2.71
(m, 2H), 2.59–2.53 (m, 3H), 1.77–1.67 (m, 4H), 1.24 (d, J = 6 Hz,
3H); 13C NMR (75 MHz, CDCl3) d ppm: 97.50, 79.95, 73.00, 72.63,
70.94, 70.39, 70.27, 69.86, 69.69, 69.33, 67.66, 58.60, 54.70,
54.43, 54.38, 52.04, 31.55, 27.42, 17.65; MS (EI): 392.2 [M+H]+,
414.2 [M+Na]+.
A mixture of bis-chloro derivative 8 or 9 (11 mmol) and NaI
(6.60 g, 44 mmol) in dry acetone (120 mL) was stirred under reflux
for 40 h. After cooling, the precipitate was filtered and washed
with acetone. The combined acetone solutions were evaporated
in vacuum. The residue was dissolved in a mixture of CHCl3
(80 mL) and water (80 mL), the layers were separated and the or-
ganic phase was washed with water and dried (MgSO4). Evapora-
tion of the solvent afforded the products 10 and 11 as yellow
oils, which were used without further purification.
HRMS calcd for C19H37NO7 391.2570 found 391.2573. Anal.
Calcd for C19H37NO7: C, 58.29; H, 9.53. Found C, 58.34; H, 9.47.
3.2.8.1. Methyl-2,6-dideoxy-3,4-bis[(2-iodoethoxy)ethyl]-
a
-
D
-
3.2.9.3.
Methyl-6-O-(4-methoxyphenyl)-2,3,4-trideoxy-a-D-
ribo-hexopyranoside (10). Yield: 6.08 g (99%); ½a D22
ꢀ
+59.6 (c 1,
ribo-hexopyranosido-[3,4-h]-N-(3-hydroxy)propyl-1,4,7,10-tet-
raoxa-13-azacyclopentadecane (14). Chromatography on silica
gel using CHCl3:CH3OH = 100:7 as an eluent to afford 14 (2.13 g,
CH3OH); 1H NMR (CDCl3, 300 MHz), d (ppm) 4.70 (d, J = 3 Hz,
1H), 3.79–3.72 (m, 5H), 3.70–3.61 (m, 7H), 3.58–3.49 (m, 2H),
3.42 (s, 3H), 3.26 (td, J = 6.6 Hz, 2.1 Hz, 4H), 3.04 (ddd, J = 10.8 Hz,
9.4 Hz, 4.2 Hz, 1H), 2.30 (dt, J = 11.4 Hz, 4.5 Hz, 1H), 1.73 (q,
J = 11.7 Hz, 1H), 1.24 (d, J = 6.6 Hz, 3H). 13C NMR (CDCl3, 75 MHz),
d (ppm): 97.38, 72.40, 71.76, 71.29, 71.20, 71.11, 70.72, 70.33,
66.32, 64.09, 55.31, 35.07, 17.68, 3.17, 3.11. HRMS calcd for
79%). ½a 2D2
ꢀ
+137.3 (c 1, CHCl3); 1H NMR (CDCl3, 500 MHz), d
(ppm): 6.89 (d, J = 9 Hz, 2H), 6.81 (d, J = 9 Hz, 2H), 4.95 (br s, OH),
4.74 (d, J = 4 Hz, 1H), 4.34 (d, J = 9.5 Hz, 1H), 4.21 (dd, J = 10 Hz,
4 Hz, 1H), 4.16–4.11 (m, 2H), 3.91–3.83 (m, 2H), 3.81–3.74 (m,
6H), 3.72–3.45 (m, 12H), 3.33 (s, 3H), 2.87–2.56 (m, 5H), 2.24
(dd, J = 15 Hz, 2 Hz, 2H), 1.76 (dt, J = 15 Hz, 4 Hz, 1H).
C15H28I2O6 557.9975 found 557.9971.
13C NMR (75 MHz, CDCl3) d ppm: 153.84, 153.28, 115.78,
114.52, 97.97, 75.49, 71.22, 70.46, 70.29, 69.29, 68.96, 68.61,
68.51, 68.14, 65.79, 63.79, 56.52, 55.70, 55.17, 54.27, 54.20,
31.74, 28.41; MS (EI): 500.2 [M+H]+, 522.0 [M+Na]+
3.2.8.2.
Methyl-2-deoxy-6-O-(4-methoxyphenyl)-3,4-bis[(2-
-ribo-hexopyranoside (11). Yield: 7.41 g
+64.3 (c 1, CHCl3); 1H NMR (CDCl3, 300 MHz), d
iodoethoxy)ethyl]-a-D
(99%); ½a 2D2
ꢀ
(ppm) 6.90 (d, J = 9 Hz, 2H), 6.83 (d, J = 9 Hz, 2H), 4.76 (d,
J = 4.2 Hz, 1H), 4.33–4.26 (m, 1H), 4.21 (dd, J = 10.2 Hz, 3.6 Hz,
1H), 4.16 (dd, J = 10.2 Hz, 2.1 Hz, 1H), 4.07 (dd, J = 6 Hz, 3.1 Hz,
1H), 3.84–3.77 (m, 4H), 3.77 (s, 3H), 3.75–3.54 (m, 9H), 3.35 (s,
3H), 3.27 (t, J = 6.9 Hz, 2H), 3.12 (t, J = 6.9 Hz, 2H), 2.23 (dd,
J = 15 Hz, 3 Hz, 1H), 1.84 (dt, J = 15 Hz, 3.6 Hz, 1H). 13C NMR (CDCl3,
75 MHz), d (ppm): 154.02, 153.16, 115.88, 114.47, 96.52, 71.78,
71.30, 71.26, 71.15, 70.74, 70.27, 68.63, 67.59, 67.28, 66.86,
55.71, 55.32, 34.77, 3.16, 3.10.
HRMS calcd for C25H41NO9 499.2781 found 499.2785. Anal.
Calcd for C25H41NO9: C, 60.10; H, 8.27. Found C, 60.06; H, 8.21.
3.2.9.4. Methyl-6-O-(4-methoxyphenyl)-2,3,4-trideoxy-a-D-ribo-
hexopyranosido-[3,4-h]-N-(3-methoxy)propyl-1,4,7,10-tetraox-
a-13-azacyclopentadecane (15).
Yield: 2.32 g (84%); ½a D22
ꢀ
+120
(c 1, CHCl3); 1H NMR (CDCl3, 500 MHz), d (ppm): 6.93 (d, J = 8.5 Hz,
2H), 6.82 (d, J = 8.5 Hz, 2H), 4.75 (d, J = 3.5 Hz, 1H), 4.49 (dd,
J = 18 Hz, 10.5 Hz, 1H), 4.33–4.08 (m, 3H), 3.95–3.78 (m, 6H),
3.76 (s, 3H), 3.72–3.45 (m, 11H), 3.37 (s, 3H), 3.33 (s, 3H), 2.83–
2.75 (m, 2H), 2.71–2.64 (m, 2H), 2.59–2.52 (m, 1H), 2.36–2.22
(m, 1H), 1.91–1.72 (m, 2H); 13C NMR (75 MHz, CDCl3) d ppm:
153.88, 153.16, 115.72, 114.55, 97.96, 75.85, 71.27, 70.78, 70.74,
70.22, 69.58, 69.39, 68.30, 68.26, 68.05, 65.78, 58.65, 55.70,
55.27, 54.70, 53.75, 53.70, 31.89, 27.18; MS (EI): 514.3 [M+H]+,
536.2 [M+Na]+; HRMS calcd for C26H43NO9 513.2938 found
513.2935. Anal. Calcd for C26H43NO9: C, 60.80; H 8.44. Found C,
60.84; H 8.50.
HRMS calcd for C22H34I2O8 680.0343 found 680.0338.
3.2.9. General method for the preparation of lariat ethers 12–15
A mixture of anhydrous Na2CO3 (3.43 g, 32.4 mmol), the corre-
sponding primary amine: 3-hydroxypropylamine (0.41 mL,
5.4 mmol) or 3-methoxypropylamine (0.44 mL, 5.4 mmol) and
bis-iodo compound 10 or 11 (5.4 mmol) in dry acetonitrile
(90 mL) was stirred and refluxed for 30–40 h, under argon. After
cooling, the precipitate was filtered and washed with acetonitrile.
The combined organic solutions were concentrated in vacuo. The
residual oil was dissolved in CHCl3, washed with water and dried
(MgSO4), and the solvent was evaporated. The crude monoaza-lar-
iat ethers (12–15) were purified by column chromatography on sil-
ica gel using CHCl3/CH3OH (100:5–100:10) as an eluent.
3.3. Synthesis of altrose-based monoaza-15-crown-5
compounds (19–20)
3.3.1. Methyl-2,3-anhydro-4,6-O-benzilidene-a-D-
mannopyranoside (17)26
3.2.9.1. Metyl-2,3,4,6-tetradeoxy-
a
-
D
-ribo-hexopyranosido-[3,
Suspension of 60% NaH (4.2 g, 0.105 mol) was washed with dry
hexane to remove the paraffin, and then was added to dry DMF
(400 mL). To this suspension 16 (14.1 g, 0.05 mol) was added and
the mixture was stirred for 1 h, then N-p-toluenesulfonyl imidaz-
ole (11.91 g, 0.054 mol) was added. After stirring for 2 h at rt the
mixture was poured into ice-water (2000 mL). The precipitate
was filtered and washed with water until the filtrate remained col-
ourless. The crude product was purified by flash chromatography
on silica gel using hexane/EtOAc = 2:1 as an eluent to afford 17
4-h]-N-(3-hydroxy)propyl-1,4,7,10-tetraoxa-13-azacyclopenta-
decane (12). Yield: 0.93 g (46%); ½a D22
ꢀ
+78.5 (c 1, CHCl3); 1H NMR
(CDCl3, 500 MHz), d (ppm) 4.90 (br s, OH), 4.60 (d, J = 3 Hz, 1H),
3.91 (td, J = 12 Hz, 4 Hz, 2H), 3.79 (t, J = 5 Hz, 2H), 3.67–3.56 (m,
9H), 3.55–3.49 (m, 3H), 3.41 (s, 3H), 3.16 (td, J = 10 Hz, 4 Hz, 1H),
2.84–2.73 (m, 4H), 2.67 (t, J = 5.5 Hz, 2H), 2.58–2.53 (m, 1H),
1.73–1.64 (m, 3H), 1.23 (d, J = 6 Hz, 3H); 13C NMR (75 MHz, CDCl3)
d ppm: 97.59, 80.07, 73.01, 72.70, 70.05, 69.91, 69.32, 69.30, 69.27,
67.61, 63.88, 56.52, 54.75, 54.68, 54.26, 31.40, 28.29, 17.63; MS
(EI): 378.3 [M+H]+ 400.3 [M+Na]+; HRMS calcd for C18H35NO7
377.2414 found 377.2410. Anal. Calcd for C18H35NO7: C, 57.27; H,
9.35. Found C, 57.32; H 9.41.
(5.76 g, 44%); ½a D22
ꢀ
+104 (c 1, CHCl3); Lit.35
½
a 2D2
+103 (c 1, CHCl3);
ꢀ
Mp: 148 °C
1H NMR (CDCl3, 500 MHz), d (ppm) 7.51–7.48 (m, 2H), 7.41–
7.36 (m, 3H), 5.57 (s, 1H), 4.90 (s, 1H), 4.26 (d, J = 5.5 Hz, 1H),
3.76–3.66 (m, 3H), 3.49–3.47 (m, 1H), 3.47 (s, 3H), 3.17
(d, J = 3.5 Hz, 1H). 13C NMR (75 MHz, CDCl3) d ppm: 137.80,
129.21, 128.30, 126.29, 102.02, 98.29, 78.80, 68.95, 66.98, 55.85,
3.2.9.2. Metyl-2,3,4,6-tetradeoxy-a-D-ribo-hexopyranosido-[3,4-
h]-N-(3-methoxy)propyl-1,4,7,10-tetraoxa-13-azacyclopentade-